COVID-19 Vaccine Effectiveness Among Health Workers in Georgia
NCT04868448 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600
Last updated 2021-05-03
Summary
This is a prospective one-year cohort study of hospital-based health workers in Georgia to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection and COVID-19 disease.
Conditions
- Covid19
Interventions
- BIOLOGICAL
-
Covid-19 vaccines
Observation of individuals who received one or more doses of covid-19 vaccines.
Sponsors & Collaborators
- collaborator OTHER
-
National Center for Disease control and Public Health
lead OTHER_GOV
Principal Investigators
-
Khatuna C Zakhashvili, MD · National Center for Disease control and Public Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-20
- Primary Completion
- 2022-08-01
- Completion
- 2022-08-01
Countries
- Georgia
Study Locations
More Related Trials
-
A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above
NCT04847102 ·Status: UNKNOWN ·Phase: PHASE3
-
COVID-19 Vaccines Safety Tracking (CoVaST)
NCT04834869 ·Status: RECRUITING
-
Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)
NCT05128721 ·Status: UNKNOWN ·Phase: PHASE1
-
Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)
NCT05534009 ·Status: RECRUITING
-
GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)
NCT04673149 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
NCT04860258 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov)
NCT05398848 ·Status: COMPLETED ·Phase: PHASE3
-
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations
NCT04853004 ·Status: ACTIVE_NOT_RECRUITING
-
Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults
NCT04783311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
NCT05047692 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
NCT04546841 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
NCT04453488 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older
NCT05726084 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers
NCT04683484 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
NCT05603052 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Evaluation of Covid-19 Vaccines Response
NCT04895007 ·Status: UNKNOWN
-
The Influence of Trained Immunity in COVID-19 Vaccinated Individuals
NCT05705180 ·Status: UNKNOWN
-
Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers
NCT04996238 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity
NCT04789356 ·Status: UNKNOWN ·Phase: PHASE4
-
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
NCT05126550 ·Status: UNKNOWN
-
Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns
NCT04854408 ·Status: COMPLETED
-
A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults
NCT05037097 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19
NCT04869592 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects
NCT04563702 ·Status: COMPLETED ·Phase: PHASE1
-
Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations
NCT04765839 ·Status: COMPLETED ·Phase: NA